GlassScriptPhysician profile
Chad Harman Jackson
NPI 1184067498
$1,077.18
in general payments reported to CMS, 2019-2025
15 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $12.21 · 2021: $74.04 · 2022: $350 · 2023: $36.43 · 2024: $303 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $321.32 | 2021-2022 | |
| Amgen INC. | $187.07 | 2024-2025 | Tepezza |
| Allergan, INC. | $108.28 | 2019 | |
| Biotissue Holdings INC. | $71.99 | 2025 | |
| Stryker Corporation | $67.49 | 2024 | Neptune, Stryker |
| Merz Pharmaceuticals, LLC | $64.32 | 2023-2024 | Xeomin |
| Mentor Worldwide LLC | $47.05 | 2024-2025 | Stratafix |
| Depuy Synthes Sales INC. | $46.64 | 2021-2022 | |
| New World Medical,INC. | $37.87 | 2022 | |
| Stimlabs LLC | $30.16 | 2025 | Allacor P |
| Mimedx Group, INC. | $24.47 | 2024 | |
| Abbvie INC. | $20.28 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $19.41 | 2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $18.62 | 2022 | |
| Glaukos Corporation | $12.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.